Moroxydine
Moroxydine is an antiviral drug that was originally developed in the 1950s as an influenza treatment. It has potential applications against a number of RNA and DNA viruses.[1] Structurally moroxydine is a heterocyclic biguanidine.
![]() | |
| Names | |
|---|---|
| IUPAC name
N-(Diaminomethylidene)morpholine-4-carboximidamide | |
| Other names
Moroxidine | |
| Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
| ChemSpider | |
| ECHA InfoCard | 100.020.994 |
| EC Number |
|
| KEGG | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
InChI
| |
SMILES
| |
| Properties | |
Chemical formula |
C6H13N5O |
| Molar mass | 171.20 g/mol |
| Pharmacology | |
| J05AX01 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
References
- Sheppard, S. (1994). "Moroxydine: The story of a mislaid antiviral". Acta dermato-venereologica. Supplementum. 183: 1–9. PMID 9868507.
| Wikispecies has information related to Moroxydine. |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
